Dramatic Improvement of Severe Cicatricial Ectropion after Discontinuing Long-Term Erlotinib Therapy in a Patient with Lung Cancer | Zendy

AI Assistant Blog Pricing

Open Access

Dramatic Improvement of Severe Cicatricial Ectropion after Discontinuing Long-Term Erlotinib Therapy in a Patient with Lung Cancer

Author(s) -

Mehmet Serhat Mangan

Publication year - 2022

Publication title -

turkish journal of ophthalmology

Language(s) - English

Resource type - Journals

eISSN - 2147-2661

pISSN - 1300-0659

DOI - 10.4274/tjo.galenos.2021.73004

Subject(s) - medicine , erlotinib , ectropion , surgery , erlotinib hydrochloride , dermatology , eyelid , corneal perforation , cancer , visual acuity , epidermal growth factor receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.